Biology Reference
In-Depth Information
[11] Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, et al. Recipient nonhe-
matopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-
host disease. Nat Med 2012;18:135-42.
[12] Rollins BJ. Chemokines. Blood 1997;90:909-28.
[13] Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol
2001;2:102-7.
[14] Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The
functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem
1995;270:27348-57.
[15] Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Im-
munity 2001;14:377-86.
[16] Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol
2001;2:123-8.
[17] Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15.
[18] Cooke KR, Serody JS, Welniak LA, Murphy WJ. Chemokines and graft-versus-host dis-
ease. In: Ferrara J, Cooke K, Deeg HJ, editors. Graft-vs.-Host Disease. 3rd ed. New York:
Dekker; 2005. p. 125-53.
[19] DiPersio JF, Uy GL, Yasothan U, Kirkpatrick P. Plerixafor. Nat Rev Drug Discovery
2009;8:105-6.
[20] Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I, et al. The
chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular
endothelium under shear flow. J Clin Invest 1999;104:1199-211.
[21] Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. Defects
of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC che-
mokine PBSF/SDF-1. Nature 1996;382:635-8.
[22] Adams GB, Chabner KT, Foxall RB, Weibrecht KW, Rodrigues NP, Dombkowski D, et al.
Heterologous cells cooperate to augment stem cell migration, homing, and engraft-
ment. Blood 2003;101:45-51.
[23] Christopherson 2nd KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/di-
peptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated
chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002;169:7000-8.
[24] Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the reten-
tion of B lineage and granulocytic precursors within the bone marrow microenviron-
ment. Immunity 1999;10:463-71.
[25] Wiesmann A, Spangrude GJ. Marrow engraftment of hematopoietic stem and pro-
genitor cells is independent of Galphai-coupled chemokine receptors. Exp Hematol
1999;27:946-55.
[26] Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem
cells are uniquely selective in their migratory response to chemokines. J Exp Med
2002;195:1145-54.
[27] Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, et al. Memory CD4+
T cells do not induce graft-versus-host disease. J Clin Invest 2003;112:101-8.
[28] Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62L− memory
T cells without graft-versus-host disease. Blood 2004;103:1534-41.
[29] Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, et al. CCR7 coor-
dinates the primary immune response by establishing functional microenvironments
in secondary lymphoid organs. Cell 1999;99:23-33.
[30] Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, West ML, Burgents JE, Blazar BR, et al.
Separation of graft-versus-host disease from graft-versus-leukemia responses by target-
ing CC-chemokine receptor 7 on donor T cells. Blood 2010;115:4914-22.
[31] Yakoub-Agha I, Saule P, Depil S, Micol JB, Grutzmacher C, Boulanger-Villard F, et al. A
high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine
receptor CCR7 increases incidence and severity of acute graft-versus-host disease in
patients undergoing allogeneic stem cell transplantation for hematological malignancy.
Leukemia 2006;20:1557-65.
[32] Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin
Immunol 2003;15:5-14.
[33] Choi SW, Hildebrandt GC, Olkiewicz KM, Hanauer DA, Chaudhary MN, Silva IA,
et al. CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell
responses and graft-versus-host disease following stem-cell transplantation. Blood
2007;110:3447-55.
[34] Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukocyte Biol
2002;71:173-83.
[35] Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al. Toll-
like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science
2002;298:1025-9.
420
Search WWH ::
Custom Search